Close

SELLAS (SLS) Announces Notice of Allowance from USPTO Covering Composition of Matter for WT-1 Peptides

March 15, 2018 8:49 AM EDT Send to a Friend
SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS” or the “Company”), a clinical-stage biopharmaceutical company focused on novel cancer immunotherapies ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login